NASDAQ:TECH

Bio-techne Stock Insider Trading

Healthcare > Biotechnology

Buy TECH

*Your capital is at risk

$72.09

+0.0600 (+0.0833%)

At Close: Jul 31, 2026

Bio-Techne Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 28.09. In total, the insiders bought 1.06M and sold 357.9K TECH shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	28.09
● Buy	1.06M shares
● Sell	357.9K shares
76% Buy Activity Moderate Positive Correlation
Sell Signal Low Confidence Jul 28, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 28.09. Partially supported by a positive historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 01, 2026 Buy	Stock Option (right to buy)	Crouse Steven C. President - Diag & Spatial Bi	CEO / President	19 032 Value: $2.29M
Mar 01, 2026 Buy	Stock Option (right to buy)	Crouse Steven C. President - Diag & Spatial Bi	CEO / President	7 327 Value: $538.2K
Feb 17, 2026 Sell	Common Stock S-Sale	Herr Amy E. Director	Director	1 976 Value: $116.8K
Feb 03, 2026 Buy	Restricted Stock Units M-Exempt	Herr Amy E. Director	Director	38 Value: $2K
Feb 03, 2026 Buy	Common Stock M-Exempt	Herr Amy E. Director	Director	38 Value: $2K
Feb 03, 2026 Sell	Common Stock F-InKind	Herr Amy E. Director	Director	16 Value: $1K
Feb 01, 2026 Buy	Restricted Stock Units M-Exempt	Mcmanus Matthew President - Diag & Spatial Bio	CEO / President	4 621 Value: $333.1K
Feb 01, 2026 Buy	Common Stock M-Exempt	Mcmanus Matthew President - Diag & Spatial Bio	CEO / President	4 621 Value: $333.1K
Feb 01, 2026 Sell	Common Stock F-InKind	Mcmanus Matthew President - Diag & Spatial Bio	CEO / President	1 665 Value: $106.7K
Nov 03, 2025 Sell	Common Stock F-InKind	Kelderman Kim Chief Executive Officer	CEO / President	2 303 Value: $144.1K
Nov 03, 2025 Buy	Common Stock M-Exempt	Hippel James CFO	C-Suite Officer	11 545 Value: $707.2K
Nov 03, 2025 Buy	Common Stock M-Exempt	Hippel James CFO	C-Suite Officer	13 159 Value: $806.1K
Nov 03, 2025 Sell	Common Stock F-InKind	Hippel James CFO	C-Suite Officer	11 865 Value: $742.4K
Nov 03, 2025 Buy	Restricted Stock Units M-Exempt	Hippel James CFO	C-Suite Officer	11 545 Value: $707.2K
Nov 03, 2025 Buy	Restricted Stock Units M-Exempt	Geist William President, Protein Sciences	CEO / President	9 911 Value: $607.1K
Nov 03, 2025 Buy	Restricted Stock Units M-Exempt	Hippel James CFO	C-Suite Officer	13 159 Value: $806.1K
Nov 03, 2025 Buy	Common Stock M-Exempt	Geist William President, Protein Sciences	CEO / President	9 911 Value: $607.1K
Nov 03, 2025 Sell	Common Stock F-InKind	Geist William President, Protein Sciences	CEO / President	4 520 Value: $282.8K
Oct 30, 2025 Buy	Common Stock A-Award	Vessey Rupert Director	Director	1 640 Value: $100.0K
Oct 30, 2025 Buy	Stock Option (Right to Buy) A-Award	Klimovsky Judith V. Director	Director	3 777 Value: $230.2K
Oct 30, 2025 Buy	Stock Options (Right to Buy) A-Award	Seth Alpna Director	Director	3 777 Value: $230.2K
Oct 30, 2025 Buy	Common Stock A-Award	Seth Alpna Director	Director	1 640 Value: $100.0K
Oct 30, 2025 Buy	Stock Options (Right to Buy) A-Award	Higgins John L Director	Director	3 777 Value: $230.2K
Oct 30, 2025 Buy	Stock Options (Right to Buy) A-Award	Bushman Julie L Director	Director	3 777 Value: $230.2K
Oct 30, 2025 Buy	Common Stock A-Award	Bushman Julie L Director	Director	1 640 Value: $100.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT BIO-TECHNE CORP

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, and diagnostics and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment provides biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, s...

Read Full Profile Here